SYGNIA ITRIX (RF) PROPRIETARY LIMITED - CANCELLATION OF S457943 Index Constituent Change - SYGH

CANCELLATION OF S457943 Index Constituent Change - SYGH

SYGNIA ITRIX COLLECTIVE INVESTMENT SCHEME
Sygnia Itrix Solactive Healthcare 150 ETF
JSE Code: SYGH
ISIN: ZAE000300521


A portfolio in the Sygnia Itrix Collective Investment Scheme in
Securities, registered as such in terms of the Collective Investment
Schemes Control Act, 45 of 2002.

INDEX CONSTITUENT CHANGE - SYGH

In terms of section 19.28 of the JSE Limited Listings Requirements,
notice is hereby given to investors of the above ETF securities that
the following changes in the constituents of the underlying index in
the table below is effective from 01 March 2022.


The following constituents have been added to SYGH:

                                             
                Share                          Previous         New Weight
ISIN                                           Weight
GB0009633180    DECHRA PHARMACEUTICALS PLC       0.00%           0.08%
US29415F1049    ENVISTA HOLDINGS CORP            0.00%           0.09%
US8753722037    TANDEM DIABETES CARE INC         0.00%           0.10%
US88033G4073    TENET HEALTHCARE CORP            0.00%           0.11%
CH0364749348    VIFOR PHARMA AG                  0.00%           0.10%

The following constituents have been removed from SYGH:

                                             
                 Share                         Previous         New Weight
ISIN                                           Weight
DK0060227585     CHR HANSEN HOLDING AS           0.11%           0.00%
CH0334081137     CRISPR THERAPEUTICS AG          0.05%           0.00%
DK0060336014     NOVOZYMES AS CLASS B            0.18%           0.00%


The above gave affect to changes in the index constituent weights.
The portfolio composition file can be viewed at www.sygnia.co.za/etfs/etf-and-etn-fund-range.

02 March 2022

Manager
Sygnia Itrix (RF) Pty Limited


JSE Sponsor
Vunani

Date: 02-03-2022 03:29:59
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.